LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Integra LifeSciences to Shift PriMatrix, SurgiMend Production to New Braintree, Massachusetts Facility by 2026 MT
Morgan Stanley Raises Price Target on Integra LifeSciences to $27 From $24, Keeps Underweight Rating MT
Integra LifeSciences Holdings Corporation Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) added to Russell 2000 Defensive Index CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from Russell Midcap Value Index CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from Russell 1000 Index CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) added to Russell 2000 Index CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) added to Russell 2000 Value Index CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) added to Russell 2000 Value-Defensive Index CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) added to Russell 2000 Dynamic Index CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from Russell Midcap Index CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from Russell 1000 Value Index CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from Russell 1000 Dynamic Index CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) added to S&P 600 Health Care CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) added to S&P 600 CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from S&P 400 Health Care CI
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from S&P 400 CI
KKR & Co, CrowdStrike, GoDaddy to Join S&P 500 Index on June 24 MT
Integra Lifesciences Holdings Insider Bought Shares Worth $1,499,979, According to a Recent SEC Filing MT
Integra Lifesciences Holdings Insider Bought Shares Worth $995,816, According to a Recent SEC Filing MT
Sector Update: Health Care Stocks Steady Pre-Bell Friday MT
Integra LifeSciences Holdings to Repurchase $50 Million in Shares MT
Transcript : Integra LifeSciences Holdings Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 01:40 PM
Truist Cuts Price Target on Integra LifeSciences Holdings to $25 From $37, Keeps Hold Rating MT
Wells Fargo Downgrades Integra LifeSciences Holdings to Equalweight From Overweight, Cuts Price Target to $25 From $45 MT
Chart Integra LifeSciences Holdings Corporation
More charts
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
29.84 USD
Average target price
34.7 USD
Spread / Average Target
+16.29%
Consensus
  1. Stock Market
  2. Equities
  3. IART Stock
  4. News Integra LifeSciences Holdings Corporation
  5. Morgan Stanley Raises Price Target on Integra LifeSciences to $27 From $24, Keeps Underweight Rating